Evidence map›Paper›PMID 29133484›Full record

ArticleThe Journal of cell biology2018

Loss of E-cadherin provides tolerance to centrosome amplification in epithelial cancer cells.

Alexander D Rhys, Pedro Monteiro, Christopher Smith, Malti Vaghela, Teresa Arnandis, Takuya Kato, Birgit Leitinger, Erik Sahai, Andrew McAinsh, Guillaume Charras and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Surviving the Storm: The Role of Poly- and Depolyploidization in Tissues and Tumors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Alexander D RhysBarts Cancer Institute-CRUK Centre, Queen Mary University of London, John Vane Science Centre, London, England, UK.
Pedro MonteiroBarts Cancer Institute-CRUK Centre, Queen Mary University of London, John Vane Science Centre, London, England, UK.
Christopher SmithCentre for Mechanochemical Cell Biology, Division of Biomedical Science, Warwick Medical School, University of Warwick, Coventry, England, UK.ORCID 0000-0002-5035-6828
Malti VaghelaLondon Centre for Nanotechnology, University College London, London, England, UK.ORCID 0000-0003-3656-1961
Teresa ArnandisBarts Cancer Institute-CRUK Centre, Queen Mary University of London, John Vane Science Centre, London, England, UK.
Takuya KatoTumour Cell Biology Laboratory, Francis Crick Institute, London, England, UK.
Birgit LeitingerMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, London, England, UK.ORCID 0000-0003-2426-1179
Erik SahaiTumour Cell Biology Laboratory, Francis Crick Institute, London, England, UK.
Andrew McAinshCentre for Mechanochemical Cell Biology, Division of Biomedical Science, Warwick Medical School, University of Warwick, Coventry, England, UK.ORCID 0000-0001-6808-0711
Guillaume CharrasLondon Centre for Nanotechnology, University College London, London, England, UK.
Susana A GodinhoBarts Cancer Institute-CRUK Centre, Queen Mary University of London, John Vane Science Centre, London, England, UK s.godinho@qmul.ac.uk.ORCID 0000-0003-0638-065X
Queen Mary University of London · GBLondon Centre for Nanotechnology · GBThe Francis Crick Institute · GBUniversity of Warwick · GBImperial College London · GB

Funding

Cancer Research UKMedical Research Council MR/M010414/1
6 · The paper itself

Abstract

Centrosome amplification is a common feature of human tumors. To survive, cancer cells cluster extra centrosomes during mitosis, avoiding the detrimental effects of multipolar divisions. However, it is unclear whether clustering requires adaptation or is inherent to all cells. Here, we show that cells have varied abilities to cluster extra centrosomes. Epithelial cells are innately inefficient at clustering even in the presence of HSET/KIFC1, which is essential but not sufficient to promote clustering. The presence of E-cadherin decreases cortical contractility during mitosis through a signaling cascade leading to multipolar divisions, and its knockout promotes clustering and survival of cells with multiple centrosomes. Cortical contractility restricts centrosome movement at a minimal distance required for HSET/KIFC1 to exert its function, highlighting a biphasic model for centrosome clustering. In breast cancer cell lines, increased levels of centrosome amplification are accompanied by efficient clustering and loss of E-cadherin, indicating that this is an important adaptation mechanism to centrosome amplification in cancer.

Indexed as

Breast NeoplasmsCadherinsCell CommunicationCell Line, TumorCentrosomeDiscoidin Domain Receptor 1Epithelial CellsFemaleHumansKinesinsMitosisCadherinsDDR1 protein, humanDiscoidin Domain Receptor 1KIFC1 protein, humanKinesins

Identifiers

PMID29133484
PMCPMC5748979
OpenAlexW2769680659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.